New endoscopic device helps to improves adenoma detection rates and patient healthcare
Aquilant Endoscopy has launched EndoRings, its latest endoscopic device to aid gastroenterologists in improving care of patients.
The innovative product, making its UK debut this month, easily attaches to the distal end of adult and slim colonoscopes to provide improved visibility, scope centring during screening, and anchoring during endoscopic therapy.
In a clinical study EndoRings was found to provide an improved adenoma detection rate without the need for consultants to change their technique. The device has three layers of flexible, soft circular rings that gently flatten folds within the colon during withdrawal allowing improved visibility of the colonic wall. Lesions hidden behind these folds are easily missed during standard endoscopy which can lead to a late diagnosis of cancers. Made from flexible silicon, EndoRings are supplied sterile and for single use only. The EndoRings device is compatible with all leading colonoscopes.
In a recent international multi-centre ‘CLEVER' study evaluating EndoRings in 126 patients, the adenoma detection rate was found to be 51% when using EndoRings, versus 29% with a standard colonoscope - a relative improvement of 70%. The number of polyps and adenomas detected when using EndoRings was more than twice that of standard colonoscopy.
Andrew Dawe, general manager of Aquilant Endoscopy, said: "We are excited at the introduction of EndoRings not only because we have been appointed as exclusive UK distributor, but also because this forms an important part of our strategy to further develop our portfolio of innovative world-class products that help to improve patient outcomes.”